AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE DRUG COST TRANSPARENCY ACT (Allows drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers for analysis to the director of the department of business regulation regarding prescription drugs.)
Bill status
died
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 28, 2022
Last action Mar 3, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Mar 3, 2022
Committee
03/03/2022 Committee recommended measure be held for further study
legislature
Jan 28, 2022
Introduced
01/28/2022 Introduced, referred to House Health & Human Services
lower
8 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 7245
Scope: RI
Hi! I can help you understand HB 7245. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline